A survey of diagnosis, management, and grading of chronic GVHD

Biology of Blood and Marrow Transplantation

Volumn 8, Issue 1, 2002, Pages 32-39

  Lee, Stephanie J ^a   Vogelsang, Georgia ^a   Gilman, Andrew ^a   Weisdorf, Daniel J ^a   Pavletic, Steven ^a   Antin, Joseph H ^a   Horowitz, Mary M ^a   Akpek, Gorgun ^a   Flowers, Mary E ^a   Couriel, Daniel ^a   Martin, Paul J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Allogeneic stem cell transplantation; Chronic graft versus host disease

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; PSORALEN; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY; URSODEOXYCHOLIC ACID; ANTINEOPLASTIC AGENT;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; MALE; MEDICAL DECISION MAKING; MORTALITY; PATIENT CARE; POSTAL MAIL; PRESCHOOL CHILD; PROGNOSIS; QUESTIONNAIRE; STANDARDIZATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; TREATMENT PLANNING; VACCINATION; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; DISEASE MANAGEMENT; HOSPITALIZATION; INFORMATION PROCESSING; MIDDLE AGED; PHARMACOKINETICS; STANDARD;

ADULT; ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; CHRONIC DISEASE; DATA COLLECTION; DISEASE MANAGEMENT; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION; THERAPEUTIC EQUIVALENCY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0036169694     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2002.v8.pm11846354     Document Type: Article

References (9)

1. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease
2. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation
3. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
4. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation
5. Recovery after allogeneic marrow transplantation: Prospective study of predictors of long-term physical and psychosocial functioning
6. Quality of life following bone marrow transplantation: A comparison of patient reports with population norms
7. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation
8. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry
9. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry